Delivery Order SPE2DB20D1100-SPE2DB25FE1DR
Award Date 9/25/25
Potential Completion Date 10/17/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg–900 mg suspension (6 mL) with a completion date of September 30, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded a $5,078.08 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 mg-600 mg suspension in 4 mL formulation, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the breadth of...
- The Defense Logistics Agency awarded a delivery order valued at $34,352.10 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), a long-acting injectable antiretroviral medication used in HIV treatment. This firm fixed-price delivery order, issued on June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The contract carries...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of CABENUVA ER (cabotegravir/rilpivirine) 600 mg-900 mg suspension in 6 mL vials, valued at $38,169.00. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract has an ultimate completion date of October 3, 2025, and will be performed at the awardee's location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,816.90 to supply CABENUVA ER 600 MG-900 MG Suspension 6ML, a long-acting injectable antiretroviral medication used for HIV treatment. This firm fixed price, competitively awarded delivery order is scheduled for completion by July 14, 2025, and is being performed from AmerisourceBergen's location in Conshohocken, Pennsylvania. The contract is part of the company's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $18,617.58 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation, performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the Defense...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $45,802.80 on August 1, 2025, for the supply of CABENUVA ER 600 mg-900 mg suspension in 6 mL units. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by August 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,535.20 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), a long-acting antiretroviral combination medication used in HIV treatment. Issued on September 14, 2025, with an ultimate completion date of October 3, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive award with no set-aside designation. The product will be delivered to...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL quantities. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a $5,078.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 MG-600 MG suspension (4 mL), with an ultimate completion date of August 6, 2025. This is a non-set-aside competitive award issued on July 16, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...